Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1959 2
1961 1
1963 2
1964 2
1966 2
1967 2
1968 3
1970 2
1971 5
1972 2
1973 3
1974 5
1975 8
1976 18
1977 12
1978 22
1979 19
1980 22
1981 20
1982 22
1983 37
1984 42
1985 48
1986 38
1987 53
1988 63
1989 79
1990 79
1991 90
1992 90
1993 125
1994 137
1995 197
1996 172
1997 170
1998 206
1999 223
2000 266
2001 257
2002 283
2003 315
2004 327
2005 377
2006 427
2007 457
2008 520
2009 533
2010 607
2011 675
2012 812
2013 899
2014 1005
2015 1092
2016 1115
2017 1164
2018 1280
2019 1397
2020 1308
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

15,570 results
Results by year
Filters applied: . Clear all
Page 1
Cholangiocarcinoma.
Razumilava N, Gores GJ. Razumilava N, et al. Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26. Lancet. 2014. PMID: 24581682 Free PMC article. Review.
Cholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are undertaken for cholangiocarcinomas of different anatomical locations (intrahepatic, perihilar, and dist
Cholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis and poor outcomes. Specific diagnostic a
Cholangiocarcinoma - evolving concepts and therapeutic strategies.
Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Rizvi S, et al. Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10. Nat Rev Clin Oncol. 2018. PMID: 28994423 Free PMC article. Review.
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholangiocyte differentiation: cholangiocarcinomas are categorized according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). ...Targeting
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholangiocyte differentiation: chola
Cholangiocarcinoma.
Krasinskas AM. Krasinskas AM. Surg Pathol Clin. 2018 Jun;11(2):403-429. doi: 10.1016/j.path.2018.02.005. Surg Pathol Clin. 2018. PMID: 29751883 Review.
This article focuses on cholangiocarcinoma, both intrahepatic and extrahepatic. The various classification schemes based on anatomic location, macroscopic growth pattern, microscopic features, and cell of origin are outlined. The clinicopathologic, immunohistochemical and …
This article focuses on cholangiocarcinoma, both intrahepatic and extrahepatic. The various classification schemes based on anatomic …
Cholangiocarcinoma.
Khan AS, Dageforde LA. Khan AS, et al. Surg Clin North Am. 2019 Apr;99(2):315-335. doi: 10.1016/j.suc.2018.12.004. Epub 2019 Feb 10. Surg Clin North Am. 2019. PMID: 30846037 Review.
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world. Cholangiocarcinoma arises from the malignant growth of the epithelial lining of the bile ducts and can be found all along the biliary
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world.
Update on the Diagnosis and Treatment of Cholangiocarcinoma.
Doherty B, Nambudiri VE, Palmer WC. Doherty B, et al. Curr Gastroenterol Rep. 2017 Jan;19(1):2. doi: 10.1007/s11894-017-0542-4. Curr Gastroenterol Rep. 2017. PMID: 28110453 Review.
PURPOSE OF REVIEW: Cholangiocarcinoma is a rare biliary adenocarcinoma associated with poor outcomes. Cholangiocarcinoma is subdivided into extrahepatic and intrahepatic variants. Intrahepatic cholangiocarcinoma is then further differentiated into (1) periphe …
PURPOSE OF REVIEW: Cholangiocarcinoma is a rare biliary adenocarcinoma associated with poor outcomes. Cholangiocarcinoma is su …
Molecular Pathogenesis of Cholangiocarcinoma.
Labib PL, Goodchild G, Pereira SP. Labib PL, et al. BMC Cancer. 2019 Feb 28;19(1):185. doi: 10.1186/s12885-019-5391-0. BMC Cancer. 2019. PMID: 30819129 Free PMC article. Review.
BACKGROUND: Cholangiocarcinomas are a heterogeneous group of malignancies arising from a number of cells of origin along the biliary tree. ...This review summarises the evidence behind reported risk factors and current understanding of the molecular pathogenesis of chol
BACKGROUND: Cholangiocarcinomas are a heterogeneous group of malignancies arising from a number of cells of origin along the biliary …
Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Rizvi S, Gores GJ. Rizvi S, et al. Gastroenterology. 2013 Dec;145(6):1215-29. doi: 10.1053/j.gastro.2013.10.013. Epub 2013 Oct 15. Gastroenterology. 2013. PMID: 24140396 Free PMC article. Review.
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomically as intrahepatic CCA (iCCA), perihilar CCA (pCCA), or distal CCA. ...
Cholangiocarcinomas (CCAs) are hepatobiliary cancers with features of cholangiocyte differentiation; they can be classified anatomica
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Esnaola NF, et al. Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22. Cancer. 2016. PMID: 26799932 Free article. Review.
Cholangiocarcinomas are rare biliary tract tumors that are often challenging to diagnose and treat. Cholangiocarcinomas are generally categorized as intrahepatic or extrahepatic depending on their anatomic location. The majority of patients with cholangiocarcinom
Cholangiocarcinomas are rare biliary tract tumors that are often challenging to diagnose and treat. Cholangiocarcinomas are ge
Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates.
Lee AJ, Chun YS. Lee AJ, et al. Chin Clin Oncol. 2018 Oct;7(5):52. doi: 10.21037/cco.2018.07.03. Epub 2018 Jul 12. Chin Clin Oncol. 2018. PMID: 30180751 Free article. Review.
Intrahepatic cholangiocarcinoma accounts for 5% to 30% of all primary liver cancers, and its incidence has increased in the last 3 decades. ...The 7th edition of the American Joint Committee on Cancer (AJCC) Staging Manual introduced a new staging system for intrahepatic …
Intrahepatic cholangiocarcinoma accounts for 5% to 30% of all primary liver cancers, and its incidence has increased in the last 3 de …
Liver Transplant for Cholangiocarcinoma.
Zamora-Valdes D, Heimbach JK. Zamora-Valdes D, et al. Gastroenterol Clin North Am. 2018 Jun;47(2):267-280. doi: 10.1016/j.gtc.2018.01.002. Gastroenterol Clin North Am. 2018. PMID: 29735023 Review.
Liver transplant (LT) for perihilar cholangiocarcinoma (CCA) offers an opportunity for survival among patients with early-stage but anatomically unresectable disease. ...
Liver transplant (LT) for perihilar cholangiocarcinoma (CCA) offers an opportunity for survival among patients with early-stage but a …
15,570 results
Jump to page
Feedback